INTRODUCTION
Liver disease is one of the leading causes of death in the world.
Each year, approximately 25,000 patients die from endstage liver disease in the United States alone. The orthotopic liver transplan tation is the only known treatment for patients with endstage liver failure but this therapy is limited by the shortage of donor organs.
Many alternative treatments, including hepatocyte transplanta tion [1, 2] , transplanted tissue engineered liver [35] , and extracor poreal bioartificial liver (BAL) device [6, 7] have been attempted to treat acute liver failure, but have shown limited success.
LIVER TISSUE ENGINEERING AND CELLULAR INTERACTIONS
Hepatic tissue engineering has evolved as a novel therapeutic approach for drug testing and liver regeneration with engineered hepatic grafts [810] . The reconstruction of functional hepatic tis sue is dependent on the ability to control factors that influence the cell environment, including cellmatrix interactions, soluble stim uli, and cellcell interactions [1114] . Threedimensional scaffold based tissueengineered hepatic constructs have been commonly used for tissue engineering approaches [1518] . A major challenge in the engineering of any tissue is the inability of providing a suffi cient blood supply immediately post implantation. Engineering grafts for thick complex tissues such as the liver and heart require an adequate vasculature to sustain physiological requirements since the diffusion limit for oxygen is 100200 μm [19] . This chal lenge is intensified when engineering a physiological demanding tissue such as the liver. The native liver tissue is supplied with a rich vasculature which is necessary to quench the immense de mand for oxygen and nutrients required for its continuous, vigor ous contractile activity. In addition to serving as conduits for the blood supply, endothelial cells are vital for promoting hepatocyte survival and function. Although some advances have been made in the area, none of the methods have provided an absolute solu tion for the problem. As in other tissue engineering problems, a liver regeneration system has many parameters that need to be op timized in order to enable a robust system design for restoring the function of the damaged liver. [20, 21] through mechanisms dependent on heterotypic cell-cell contacts [22, 23] . Hepatocyte morphology and function varies somewhat depending on coculture cell type [24, 25] . 
DECELLULARIZED MATRIX FOR WHOLE LIVER
Recently, whole organ decellularlization techniques have emerged as a new therapeutic strategy for organ replacement. The techni que was first reported for a decellularized organ scaffold from ca daveric hearts [27] . The perfusion decellularization method was applied to the whole organ for efficient removal of cellular compo nents and generated organ scaffolds that can maintain native ex tracellular matrix and vascular structure of the native organ. The scaffold was reseeded with cells and cultured in a perfusionbased system for the development of bioengineered whole organs. The technique was then applied for other organs, including the liver [28, 29] , lung [3032], and kidney [33] and showed great promise in regenerative medicine.
Uygun et al. [29] first reported whole liver engineering using perfusion decellularized liver scaffolds and transplantation of re cellularized liver grafts. In this study, ischemic rat livers were used for decellularization by portal vein perfusion. Liver was perfused with various concentrations of sodium dodecyl sulfate (SDS) for 
CONCLUSION
The liver is a large, complex organ involved with many meta bolic functions. Using decellularization techniques of the whole organ, researchers were able to create organ scaffolds that can main tain the extracellular matrix and vascular structure of the native organ. Although organ reengineering shows promise, further im 
